Charles T Robbins

8PUBLICATIONS
38CO-AUTHORS
Molecular targetsPredictive and prognostic markersGene and molecular therapyForest ecosystemsHaematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Apr 20, 2026
Quantification of Antibody-Drug Conjugate Targets in Head and Neck Squamous Cell Carcinoma.

|Nov 14, 2025
Mixed Molecular Subtypes Coexist in Estrogen Receptor Heterogeneous Primary Breast Cancers.

Julia Foldi, Kaitlyn Xiong, Matthew Liu

|Jul 16, 2025
Quantitative Multiplex Immunofluorescence Assay for Trophoblast Cell-Surface Antigen 2 and Human Epidermal Growth Factor Receptor 2 Expression in Breast Cancer: Toward Guiding Patient Selection for Antibody-Drug Conjugate Therapies.

Charles J Robbins, Mengni He, Nay Chan

|May 19, 2025
Validation and Prospective Testing of a High Sensitivity, Quantitative Analytic Assay for HER2 on Histopathology Slides.

Nay N N Chan, Patricia Gaule, Julia Benanto

|Apr 08, 2025
HER2 testing: evolution and update for a companion diagnostic assay.

Charles J Robbins, Katherine M Bates, David L Rimm

|Mar 06, 2025
Quantitative Protein Expression of Antibody-Drug Conjugate Targets in EGFR Mutated and Wild-type Non-Small Cell Lung Cancer.

Ioannis P Trontzas, Mengni He, Anna Wurtz

Pageof 2

Frequent Collaborators

6 joint publications

David L Rimm

5 joint publications

Katherine M Bates

3 joint publications

Mengni He

3 joint publications

Sneha Burela